Clinical Trial Update: Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating patient satisfaction after switching schizophrenia patients from risperidone to paliperidone; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA (PALIPERIDONE)
• Risperdal (risperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2009-10-20